1 64950sek
0,2 %
Date:2026-01-30Time:18:00:00Latest report:Q3-2025List:Large CapTicker:AZN
Market Cap:2 558 223 msekEnterprise Value:2 783 884 msekNet Sales:58 127 musdEarnings:9 399 musdEmployees:0ISIN:GB0009895292

Ratios

10-year key figure history for AstraZeneca turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AstraZeneca with index and moving average MA50 and MA200.

Stockprice:1 649,50
MA50:1 704,69
MA200:1 510,60
Price/MA200:9,2 %
RSI (14):42,1
Price/MA50:-3,2 %

Description

AstraZeneca is a global pharmaceutical company focused on the research, development and marketing of prescription medicines, primarily for the treatment of diseases in the therapeutic areas of respiratory, cardiovascular/metabolic and cancer. In addition to its core business, the company also has a focus on the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in all global regions and is headquartered in Cambridge, UK.

Pharmaceuticals